EXPLORE MORE CATEGORIES
- Home
- ยป
- Products & Services
- »
- Anti Cancer Injection
Anti Cancer Injection
Our product range includes a wide range of octride depot 30mg injection, pamorelin triptorelin injection powder, leuprolide acetate injection, fulzos fulvestrant injection, zoladex goserelin acetate 3.6 mg injection and enfiera rituximab 500mg injection.
Octride Depot 30MG Injection
Get Latest Price
Product Brochure
Product Details:
| Brand | Octride Depot |
| Prescription/Non prescription | Prescription |
| Treatment | Carcinoid Tumors, Acromegaly, VIPomas |
| Composition | Octreotide Depot 30 mg injection |
| Manufacturer | Sun Pharma |
| Packaging Size | Octreotide Depot 30MG Injection |
Yes! I am InterestedRequest A Callback
Pamorelin Triptorelin Injection Powder
Get Latest Price
Product Brochure
Product Details:
| Packaging Size | 1 Vial |
| Manufacturer | Dr.Reddy's |
| Composition | Triptorelin Powder |
| Brand | Pamorelin |
| Treatment | Used to Help Treat Prostate Cancer / Endometriosis |
| Dosage Form | 11.25mg |
| Prescription/Non prescription | Prescription |
| Warning and Precaution | For IM use |
| Storage | Store at or below 30 DegreeC |
| Shelf life | 2 Year |
| Packaging Type | Box |
The reconstituted product is a milky suspension
Warning: To be sold by retail on the prescription of an oncologist only.
Yes! I am InterestedRequest A Callback
Leuprolide Acetate Injection
Get Latest Price
Product Details:
| Packaging Size | 1 Vial(11.25mg) |
| Brand | Leugard Depot |
| Manufacturer | Zydus Ingenta |
| Composition | Leuprolide Acetate and Lyophilized |
| Treatment | Used to Help Treat Prostate Cancer, Breast and Endometriosis |
| Dosage Form | Injection |
| Prescription/Non prescription | Prescription |
| Storage | 25 DegreeC |
| Shelf life | 2 Years |
| Packaging Type | Box |
- Leugard 11.25 Depot
Yes! I am InterestedRequest A Callback
Fulzos Fulvestrant Injection
Get Latest Price
Product Brochure
Product Details:
| Strength | 250mg |
| Packaging Size | 5ml |
| Brand | Fulzos |
| Composition | Fulvestrant |
| Manufacturer | Adley Formulations Pvt. Ltd |
| Treatment | Used to Help Treat Breast Cancer |
| Prescription/Non prescription | Prescription |
| Form | Injection |
| Packaging Type | Box |
- 250 mg pre-filled syringe
- For Intra muscular use only
- For single use only
- Hetero Healthcare
Warning: Cytotoxic agent to be sold by retail on the prescription of an Oncologist / Cancer Hospital/Institution only.
Caution Not to be sold by retail without the presaliation of a Registered Medical Practitioner.
Batch No.ADC 2003FVA
Mfg.Lic.No-M L No M/100
Yes! I am InterestedRequest A Callback
Zoladex Goserelin Acetate 3.6 Mg Injection
Get Latest Price
Product Brochure
Product Details:
| Packaging Size | 1 Vial |
| Composition | Goserelin Acetate Implant Injection |
| Packaging | 1 Vial |
| Treatment | Used in Breast Cancer, Endometriosis, Uterine Fibroid in women and Prostate cancer in men |
| Dosage Form | Goserelin Acetate Implant Injection |
| Prescription/Non prescription | Prescription |
| Warning and Precaution | Before starting Zoladex pregnancy must be excluded for women |
| Storage | Do not store above 25 C degree |
| Manufacturer | AstraZeneca |
| Brand | Zoladex 3.6mg Injection |
| Form | Injection |
| Therapeutic Uses | Loacally advanced or metastatic prostate cancer and advanced breast cancer |
| Directions for Use | Prefilled injection |
Zoladex 3.6mg injection (Goserelin Acetate Implant ) analogue of LHRH known as Gonadotropin realising hormone.
Yes! I am InterestedRequest A Callback
Enfiera Rituximab 500mg Injection
Get Latest Price
Product Brochure
Product Details:
| Strength | 500 mg |
| Form | Injection |
| Packaging Type | Vial |
| Packaging Size | 1 Vial |
| Prescription/Non prescription | Prescription |
| Storage | 2 to 8 Degree |
| Composition | Rituximab injection |
| Brand | Enfiera 500mg |
| Manufacturer | Zydus |
Enfiera 500mg Injection is given as an injection under the supervision of doctor. You must take it in a dose as advised by the doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Yes! I am InterestedRequest A Callback
Kesimpta/Bonspri Ofatumumab 20mg Injection
Get Latest Price
Product Brochure
Product Details:
| Minimum Order Quantity | 1 Vial |
| Treatment Type | Allopathy |
| Packaging Type | Vial |
Ofatumumab injection is used in combination with chlorambucil to treat a type of cancer of the white blood cells called chronic lymphocytic leukemia (CLL) in patients who have not received any treatments in the past. It is also used in combination with fludarabine and cyclophosphamide to treat patients with relapsed CLL. This medicine is also used in patients with CLL who have already been treated with other medicines (eg, alemtuzumab, fludarabine) that did not work well.
Ofatumumab injection is also used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease.
Ofatumumab interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal body cells may also be affected by ofatumumab, other unwanted effects will also occur. Some of these may be serious and must be reported to your doctor. Some unwanted effects, such as a skin rash, may not be serious but may cause concern. Some of the unwanted effects do not occur until months or years after the medicine is used.
Additional Information:
- Item Code: Ofatumumab
- Packaging Details: 1 Pre-filled Syringe
Yes! I am InterestedRequest A Callback
Gemcitabine Hydrochloride IP Injection
Get Latest Price
Product Details:
| Packaging Size | 1 Vial |
| Treatment | Used to Help Treat Cancer |
| Prescription/Non prescription | Prescription |
| Brand | Gemcite |
| Manufacturer | Lilly |
| Strength | 1g |
| Packaging Type | Box |
| Product Code | VL7502 |
Powder for Solution for Infusion Gemcite 1g
For Intravenous Use (I.V) use only
Do Not Refrigerate
Indications, dosage and administration:
Composition:
Each vial contains:
- Gemcitabine Hydrochloride I.P. equivalent to 1g
- Gemcitabine as active ingredient, 1g Mannitol I.P. as stabilizer, 62.5mg
- Sodium Acetate I.P. as buffering agent and Hydrochloric Acid Solution I.P. (10%) and/or Sodium Hydroxide Solution I.P. (10 %) may be added for pH adjustment
- Water for Injection I.P. q.s. 25ml.
- Import License: IL/FF-000215
Yes! I am InterestedRequest A Callback
Regonat Regorafenib Tablets
Get Latest Price
Product Details:
| Packaging Size | 28 Tablets |
| Strength | 40 mg |
| Packaging Type | Bottle |
| Prescription/Non prescription | Prescription |
| Country of origin | Made in India |
Resihance RegorafenibResihance is an oral multi-kinase inhibitor by Bayer/Zydus which targets angiogenic, stromal and oncogenic (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types.By 2015 it had 2 US approvals for advanced cancers.
Additional Information:
- Item Code: 2A
- Production Capacity: 100
- Delivery Time: 2-3DAYS
- Packaging Details: 28 We deal in Regonat tablets which contains Regorafenib, Anti cancer medicines. Resihance RegorafenibResihance is an oral multi-kinase inhibitor by Bayer/Zydus which targets angiogenic, stromal and oncogenic (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types.By 2015 it had 2 US approvals for advanced cancers.
Yes! I am InterestedRequest A Callback
Trumab-150 Trastuzumab Lyophilized Powder
Get Latest Price
Product Brochure
Product Details:
| Packaging Size | 1 Vial |
| Manufacturer | Glenmark |
| Prescription/Non prescription | Prescription |
| Shelf life | 3 Years |
| Composition | Trastuzumab Lyophilized Powder |
| Brand | Trumab |
| Treatment | Used to Help Treat Breast Cancer |
| Packaging Type | Box |
Trastuzumab 150 mg Lyophilized Powder for Intravenous infusion
Each vial contains
- Each pack contains 1 vial of lyophilized powder of trastuzumab, 1 vial with 7.2 ml sterile Bacteriostatic water For injection and package insert
Excipients:
- L-histidine hydrochloride monohydrate ep 3.36 mg
- L-histidine usp-2.16 mg
- A, a- trehalose dihydrate nf-136.2 mg
- Polysorbate 20 nf p h - 0.6 mg
As directed by the physician
Store the lyophilized powder between 2°c to 8°c store the reconstituted solution between 2°c to 8''''c do not freeze the reconstituted solution. Protect from light.
Direction for use
Reconstitute the lyophilized powder with 7.2 m l of sterile bacteriostatic water for injection for intravenous infusion use within 28 days after reconstitution.
Keep out of reach of children.Do not use the reconstituted solution if it contains any visible particulate matter.
Mfg.lic.no:g/28 d/bio/02
Batch no.:b000540
Yes! I am InterestedRequest A Callback
Eleftha Trastuzumab 440mg Injection
Get Latest Price
Product Brochure
Product Details:
| Packaging Size | 1 vial |
| Manufacturer | Zydus Cadila |
| Prescription/Non prescription | Prescription |
| Composition | Trastuzumab 440mg Injection |
| Brand | Eleftha 440 Mg Injection |
| Treatment | Her2+ve Breast Cancer |
Yes! I am InterestedRequest A Callback
Atriance Nelarabine Injection
Get Latest Price
Product Details:
| Strength | 250 mg/50 ml |
| Pack Type | Vial |
| Brand | Atrabin |
| vial | Nelarabine |
Additional Information:
- Item Code: 4aa
- Production Capacity: 200
- Delivery Time: available
- Packaging Details: Nelarabine, sold under the brand names Nelabine, is a chemotherapy medication used for the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Yes! I am InterestedRequest A Callback